May 16, 2025

Upadacitinib Maintains UC Remission Through 96 Weeks

A 3-year study found that most patients with moderate to severe ulcerative colitis who responded to initial upadacitinib treatment stayed in remission through 96 weeks, with manageable side effects and consistent results across dosage groups.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

May 07, 2025

COVID-19 Vaccination May Lower Fibromyalgia Risk, Study

A large matched-cohort study found that COVID-19 vaccination was linked to a reduced risk of developing fibromyalgia among survivors, particularly in men and those with depression or anxiety.

Conexiant

May 06, 2025

Anemia Linked to Hidden Heart Strain in RA

A new study found that 1 in 3 rheumatoid arthritis patients with normal heart function on standard tests had hidden heart strain detectable only through advanced imaging, with anemia emerging as the strongest predictor.

Conexiant

May 05, 2025

New Chikungunya Vaccine Shows Strong Response

A new single-dose chikungunya vaccine produced strong immune responses in nearly all adolescents and adults in a large clinical trial, with mild and short-lived side effects.

Conexiant

April 30, 2025

New AI Sensor Diagnoses Osteoarthritis and Rheumatoid Arthritis

A new AI-assisted gold sensor distinguished osteoarthritis from rheumatoid arthritis with 98.1% accuracy by analyzing synovial fluid, offering a fast, noninvasive diagnostic option, researchers report.

Conexiant

April 29, 2025

New Oral Option Approved for GCA

The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.

Conexiant

April 29, 2025

Obesity Independently Hinders Remission in RA

Study shows BMI above 30 correlates with poorer treatment outcomes regardless of comorbidities

Conexiant

April 28, 2025

Higher Heart Risk Seen in Inflammatory Arthritis With IFG

Prediabetes in inflammatory arthritis patients raised cardiovascular risk by over twofold, researchers reported in a population-based cohort study.

Conexiant